Work

Deep and Durable Responses Following Venetoclax (ABT-199 / GDC-0199) Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from a Phase 1b Study

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.830.830

Authors: Shuo Ma, Danielle M. Brander, John F. Seymour, Thomas J. Kipps, Jacqueline C. Barrientos, Matthew S. Davids, Mary Ann Anderson, Michael Y. Choi, Constantine S. Tam, Tanita Mason-Bright, Betty Prine, Wijith Munasinghe, Ming Zhu, Su Young Kim, Rod A. Humerickhouse, Andrew W. Roberts

Institutions: Northwestern University, Duke Medical Center, Peter MacCallum Cancer Centre, University of California San Diego, Hofstra University, Dana-Farber Cancer Institute, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, AbbVie (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2405672745

FWCI: 7.511

Cites:

Cited by: 51

Related to: 10